| Website | civitastherapeuti... |
| Category | BioTech |
| Employees |
| TOTAL | $28M |
| VENTURE FUNDING TOTAL | $28M |
| Series A, 1/11 Longitude Capital Canaan Partners | $20M |
| Series A, 5/11 | $8M |
Civitas Therapeutics, Inc., a Chelsea, MA-based biopharmaceutical company focused on developing innovative pulmonary delivery therapies.